Nanofunctionalized zirconia and barium sulfate particles as bone cement additives.
Zirconia (ZrO(2)) and barium sulfate (BaSO(4)) particles were introduced into a methyl methacrylate monomer (MMA) solution with polymethyl methacrylate (PMMA) beads during polymerization to develop the following novel bone cements: bone cements with unfunctionalized ZrO(2) micron particles, bone cements with unfunctionalized ZrO(2) nanoparticles, bone cements with ZrO(2) nanoparticles functionalized with 3-(trimethoxysilyl)propyl methacrylate (TMS), bone cements with unfunctionalized BaSO(4) micron particles, bone cements with unfunctionalized BaSO(4) nanoparticles, and bone cements with BaSO(4) nanoparticles functionalized with TMS. Results demonstrated that in vitro osteoblast (bone-forming cell) densities were greater on bone cements containing BaSO(4) ceramic particles after four hours compared to control unmodified bone cements. Osteoblast densities were also greater on bone cements containing all of the ceramic particles after 24 hours compared to unmodified bone cements, particularly those bone cements containing nanofunctionalized ceramic particles. Bone cements containing ceramic particles demonstrated significantly altered mechanical properties; specifically, under tensile loading, plain bone cements and bone cements containing unfunctionalized ceramic particles exhibited brittle failure modes whereas bone cements containing nanofunctionalized ceramic particles exhibited plastic failure modes. Finally, all bone cements containing ceramic particles possessed greater radio-opacity than unmodified bone cements. In summary, the results of this study demonstrated a positive impact on the properties of traditional bone cements for orthopedic applications with the addition of unfunctionalized and TMS functionalized ceramic nanoparticles.
Gillani
Riaz
R
Division of Engineering and Department of Orthopaedics, Brown University, 184 Hope Street, Providence, RI 02912, USA.
Ercan
Batur
B
Qiao
Alex
A
Webster
Thomas J
TJ
D000268:Adhesiveness; D001466:Barium Sulfate / Q000737:chemistry*; D001843:Bone Cements / Q000737:chemistry* / Q000627:therapeutic use; D002460:Cell Line; D002470:Cell Survival; D019245:Compressive Strength; D006244:Hardness; D006801:Humans; D008422:Materials Testing; D053758:Nanoparticles / Q000737:chemistry* / Q000627:therapeutic use / Q000648:ultrastructure; D010006:Osteoblasts / Q000166:cytology* / Q000502:physiology*; D010316:Particle Size; D013718:Tensile Strength; D015040:Zirconium / Q000737:chemistry*
D001843:Bone Cements; D001466:Barium Sulfate; D015040:Zirconium; C028541:zirconium oxide